Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...
BREAKING NEWS: New federal nursing home commission members named
By
James M. Berklan
Jun 19, 2020
Top leaders in the long-term care industry lead the names announced Friday as members of the White House’s new Coronavirus Commission for Safety and Quality in Nursing Homes.
NIH: COVID rebound after Paxlovid may signal a strong immune response
By
Alicia Lasek
Oct 11, 2022
Patients who had rebound symptoms after taking Paxlovid showed a more robust immune response to SARS-CoV-2 than patients with no rebound, investigators reported.
Providers plea for support after Trump nixes COVID-19 relief talks
By
Danielle Brown
Oct 08, 2020
President Trump’s abrupt decision to halt negotiations between his staff and federal lawmakers on another COVID-19 relief bill until after the election could mean doom for residents and workers at long-term...
NIH study: Well-hydrated adults appear to live longer, healthier lives
By
Alicia Lasek
Jan 04, 2023
Seniors are more likely to have chronic conditions and show signs of advanced biological aging when underhydrated, a new study finds.
New treatment guidelines for chronic constipation in adults published
By
Alicia Lasek
May 22, 2023
The new guidelines cover management of chronic idiopathic constipation, a common disorder that affects 8% to 12% of U.S. adults.
NIH study finds high rates of persistent chronic pain among U.S. adults
By
Alicia Lasek
May 17, 2023
In the U.S., new cases of chronic pain occur more often than new cases of other common health conditions. This pain is also persistent, lasting at least one year for most people, investigators report.
NIH panel updates treatment guidelines for non-hospitalized COVID-19 patients
By
Alicia Lasek
Jan 25, 2022
A new recommended treatments list addresses the omicron variant’s current dominance and drug supply shortages.